Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20060089687 A1
Publication typeApplication
Application numberUS 11/272,994
Publication dateApr 27, 2006
Filing dateNov 14, 2005
Priority dateDec 12, 2002
Also published asUS6991644, US20040116984
Publication number11272994, 272994, US 2006/0089687 A1, US 2006/089687 A1, US 20060089687 A1, US 20060089687A1, US 2006089687 A1, US 2006089687A1, US-A1-20060089687, US-A1-2006089687, US2006/0089687A1, US2006/089687A1, US20060089687 A1, US20060089687A1, US2006089687 A1, US2006089687A1
InventorsGreg Spooner, Dean MacFarland, David Gollnick
Original AssigneeGreg Spooner, Macfarland Dean A, Gollnick David A
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
System for controlled spatially-selective epidermal pigmentation phototherapy with UVA LEDs
US 20060089687 A1
Abstract
The invention comprises a system and method for treating an exposed tissue of a patient with a light energy. A plurality of light emitting devices is optically coupled with a patient's tissue, to apply light treatments to the tissue. A driver circuit and a controller operate to drive the light emitting devices to output different intensities of light treatment to different sub-areas of the tissue being treated.
Images(6)
Previous page
Next page
Claims(19)
1. A system for treating a tissue area of a patient with light, wherein the tissue area includes a plurality of sub-areas having different levels of melanin in the different sub-areas, the system comprising:
a plurality of light emitting devices optically coupled with the tissue area, the plurality of light emitting devices configured into different regions that correspond to the different sub-areas having different levels of melanin;
a driver circuit electrically coupled with the plurality of light emitting devices and operable to drive the light emitting devices to output different intensities of light treatment to the different sub-areas; and
a controller coupled to the driver circuit and operable to control the driver circuit to drive the different regions of light emitting devices to output different intensities of light treatment to the different sub-areas based on the different levels of melanin in the different sub-areas.
2. The system of claim 1, wherein the controller operates to cause the driver circuit to drive a first region of light emitting devices, corresponding to a first sub-area of tissue having a first melanin content, to output a first light treatment, and to drive a second region of light emitting devices, corresponding to a second sub-area having a second melanin content, to output a second light treatment.
3. The system of claim 2, further including:
a first light sensing device operable to detect light reflected from the first sub-area and generates a first signal corresponding to the reflection of light from the first sub-area, the first light sensing device being coupled to the controller such that the controller receives the first signal and based, on the first signal, causes the driver circuit to drive the first region of light emitting devices to output the first light treatment, which induces tanning in the first sub-area; and
a second light sensing device operable to detect light reflected from the second sub-area and generates a second signal corresponding to the reflection of light from the second sub-area, the second light sensing device being coupled to the controller such that the controller receives the second signal and based, on the second signal, causes the driver circuit to drive the second region of light emitting devices to output the second light treatment, which induces tanning in the second sub-area.
4. The system of claim 1, wherein the light emitting devices are light emitting diodes.
5. The system of claim 1, wherein at least one of the different regions of light emitting devices includes only a single light emitting device.
6. The system of claim 1, wherein at least one of the different regions of light emitting devices includes more than one light emitting device.
7. A system for treating an area of tissue, where the area of tissue includes a plurality of different sub-areas of tissue which have different characteristics, comprising:
a plurality of light emitting devices optically coupled with the area of tissue, the light emitting devices being configured into different regions, that correspond to the different sub-areas of tissue having different characteristics;
a light sensing device operable to sense an amount of light reflected from each of the different sub-areas;
a driver circuit electrically coupled with the plurality of light emitting devices for driving a first region of the plurality of light emitting devices to output a first light treatment to a first sub-area of tissue, wherein the first light treatment is determined based on a first amount of light reflected from the first sub-area, and driving a second region of the plurality of light emitting devices to output a second light treatment to a second sub-area of tissue, wherein the second light treatment is determined based on a second amount of light reflected from the second sub-area of tissue.
8. The system of claim 7, wherein the first light treatment induces a first amount of tanning in the first sub-area.
9. The system of claim 8, wherein the second light treatment induces a second amount of tanning in the second sub-area.
10. The system of claim 7, wherein the first light treatment uses a wavelength below 400 nm.
11. The system of claim 7, wherein the first light treatment provides for an irradiance at least 100 mW/cm2 for the first sub-area.
12. The system of claim 7, wherein the first light treatment provides for a first level of irradiance for the first sub-area, and the second light treatment provides for a second level or irradiance for the second sub-area and the second level of irradiance is less that the first level or irradiance.
13. The system of claim 7, wherein the driver circuit is further operable to drive the plurality of light emitting devices to induce tanning in the area of tissue, such that the, tanning operates to provide for a more uniform distribution pigmentation in the area tissue than was present in the area of tissue prior to the induced tanning.
14. A system for treating an area of tissue, the area of tissue including a plurality of different sub-areas of tissue which have different amounts of pigmentation, comprising:
a light sensing device for sensing an amount of light reflected from each of the plurality of different sub-areas; and
a plurality of light emitting devices optically coupled with the area of tissue, the plurality of light emitting devices operable to apply a light treatment to the area of tissue based on the amount of light reflected from each of the plurality of different sub-areas, wherein the light treatment operates to reduce differences in the amount of pigmentation in different sub-areas of tissue.
15. The system of claim 14, wherein the plurality of light emitting devices apply the light treatment by generating a first amount of light to apply a first light treatment to a first sub-area of the area of tissue, and generating a second amount of light to apply a second light treatment to a second sub-area of the area of tissue.
16. The system of claim 14, wherein the plurality of light emitting devices apply a first amount of light energy to a first group of sub-areas of tissue of the area of tissue, where the first group of sub-areas of tissue have less pigmentation than a second group of sub-areas of tissue to which the first amount of light energy is not applied.
17. The system of claim 16, wherein the first amount of light energy induces a first amount of tanning in the first group of sub-areas of tissue.
18. The system of claim 16, wherein the first amount of light energy includes light having a wavelength below 400 nm.
19. The system of claim 16, wherein the first amount of light energy provides for an irradiance at least 100 mW/cm2 for the first group of sub-areas.
Description
    CLAIM OF PRIORITY
  • [0001]
    This patent application is a continuation of U.S. patent application Ser. No. 10/728,527, filed Dec. 5, 2003, which claims the benefit of U.S. Provisional Application No. 60/432,935, filed Dec. 12, 2002, each of which is hereby incorporated herein by reference.
  • TECHNICAL FIELD OF THE INVENTION
  • [0002]
    The present invention provides for spatially selective phototherapy using LEDs.
  • BACKGROUND
  • [0003]
    A number of diseases, medical or trauma conditions give rise to cosmetically undesirable pigmentary variation in human skin. Scars, temporary or permanent hypo- and hyper-pigmentation, striae (stretch marks), leukoderma, poikiloderma of Civatte, etc., are examples of conditions in which a melanin pigmentation cosmetic defect is presented by at least one component of the condition. A variety of approaches have been used to reduce the contrast between pigment variation regions, including chemical etches (“peel”), dermabrasion, laser ablation, and UV light sources.
  • [0004]
    Prior approaches for dealing with these conditions included removing the abnormally pigmented skin, or a portion of such skin with the goal of promoting new growth that contains cosmetically desirable “natural” pigmentation. Another approach provided for treating skin with UV light sources to promote the formation of melanin in melanin-deficient skin.
  • [0005]
    Ablative laser skin resurfacing, chemical peels and dermabrasion are examples of some approaches used for removing skin. UV lamps and excimer laser therapies are examples of some types of UV light sources.
  • [0006]
    Prior approaches have suffered from a lack of good control over the pigment induction. One shortcoming frequently associated with removing abnormally pigmented skin is that pigment-deficient areas of skin frequently exhibit resistance to melanogenesis or pigment induction. Thus, even after removing a portion of the pigment-deficient area of skin, and generating new growth of skin, the pigment deficiency frequently persists. In connection with providing UV treatment to pigment deficient skin, difficulties are also realized in that the spatial localization of the treatment is difficult to control and results in less than desirable outcomes.
  • BRIEF DESCRIPTION OF DRAWINGS
  • [0007]
    FIGS. 1A-1B are diagrams showing views of an embodiment of a system herein. FIG. 1B shows details of an electric console.
  • [0008]
    FIG. 2 is a graph showing the relationship between a minimum melanogensis dose and wavelength.
  • [0009]
    FIG. 3 shows an optical power output for an LED array relative to driving current.
  • [0010]
    FIG. 4 shows a portion of a selectively controllable LED array.
  • [0011]
    FIG. 5.shows a portion of a selectively controllable LED array with photodetectors.
  • [0012]
    FIG. 6 shows an LED array coupled with fibers.
  • [0013]
    FIG. 7 shows a fiber bundle couple with photodetectors, and different LEDs.
  • [0014]
    FIG. 8 is a graph showing a relationship between skin pigmentation and an intensity of back scattered light.
  • DETAILED DESCRIPTION
  • [0015]
    Generally desirable characteristics of a phototherapeutic approach to pigmentary induction would include: (i) production of a temporary-to-permanent pigmentary darkening in various skin phototypes; and (ii) an ability to target discrete and localized non-uniformities and “blend” them to produce a more uniform pigment background. An embodiment herein provides for controlling the exposure to light, so that the treatment does not result in just increasing an overall pigment background by a uniform amount (e.g., merely increasing a base level of all pigment in a treatment area). For example, an embodiment herein can provide for a relatively large area UV exposure with some type of masking, or directing a UV point source at a specific local target.
  • [0016]
    A system of an embodiment of the present invention is shown in FIG. 1A. The system 100 includes a rigid or flexible array module 102 of LEDs 104 arranged such that a high density of LEDs can be achieved. The array module 102 is placed in near, or close, contact with the skin, whereby the LEDs 104 are optically coupled with the skin such that light emitted from the LED is incident on the skin being treated. The LEDs 104 are electrically configured to allow for low voltage, high current operation. The array module 102 is electrically isolated from the patient in case direct contact with the array module 102 occurs. This isolation could be achieved by providing an electrically insulating, but optically transmissive material over the LEDs 104.
  • [0017]
    The array module 102 includes a surface structure 106 to which the LEDs are mounted. This surface structure could be formed on a printed circuit board which contains conductive paths from the LEDs 104 to a larger passive heat sink, or active cooler 120, such as water channel cooled plate. Typical heat loading from dissipation by LEDs in such an array is <1 W/cm2. For arrays containing 1000 or more LEDs, such heat loading can be in the 100's of Watts.
  • [0018]
    An umbilical supply cord 108 containing the driving current lines, temperature sensor, optical sensor and potentially low flow water for active cooling connects the array module 102 and LEDs 104 with the drive electronics console 110. Additional details of the console are shown in FIG. 1B. The console 110 contains a power supply, or driver circuit, 112 capable of providing for pulsed or CW operation of the LEDs 104, by controlling the electrical energy supplied to the LEDs. The console 110 also contains sensing circuits 1 14 to monitor the current, the array temperature, and the light flux. Further as will be discussed in more detail below a processor or controller 116 of the console operates to analyze the information from sensor or detectors in the array module 102, and to control the amount of current generated to by the driver circuit 112 to drive individual LEDs 104. Additionally a user interface 118 is provided to allow a user to control different aspects of the operation. More details related to a general structure of an LED array module and a console used to supply light energy to a patient's skin are disclosed in commonly assigned pending U.S. patent application Ser. No. 10/422,261, entitled SYSTEM AND METHOD FOR TREATING EXPOSED TISSUE WITH LIGHT EMITTING DIODES, filed Apr. 24, 2003, which is incorporated herein by reference in its entirety.
  • [0019]
    An embodiment herein provides cosmetically desirable pigmentation in the skin in a spatially and temporally controlled manner. Melanin synthesis in melanocytes, or “melanogenesis”, refers to this process. Melanogenesis can take place as a photoprotective effect in response to UV radiation, and when it occurs in response to natural or artificial UV light, it is referred to as “tanning.”
  • [0020]
    A distinct phenomenon associated with true melanogenesis also occurs upon exposure to UV and visible light. “Immediate pigment darkening” (IPD) is a transient oxidative change to the state of existing melanin, occurs mostly in darker skin phototypes. The persistence of IPD is hours to days, and is not clinically useful in itself for treating pigmentation cosmetic problems. Strong IPD in dark skin phototypes indicates that longer term (days to onset) melanogenesis will take place, and may serve as a clinical endpoint to pigmentation phototherapy. Additional discussion related to this issue is provided by, Kollias N, Malallah Y H, Al-Ajmi H, Baqer A, Johnson B E, Gonzales S. Erythema and melanogenesis action spectra in heavily pigmented individuals as compared to fair-skinned Caucasians, Photodermatol Photoimmunol Photomedicne 1996: 12: 183-188, which is incorporated herein by reference in its entirety.
  • [0021]
    As shown in FIG. 2 there is a strong dependence between melanogenesis action and wavelength, with the threshold dose rising rapidly as the wavelength increases from the end of the UVB (˜320 nm) into the blue (400 nm). Beyond 400 nm, there is very little melanogenesis. The graph shown in FIG. 2 shows the minimum melanogenic dose (MMD) for light skin people along the vertical axis. The MMD is on the order of 100 J/cm2 for 365 nm, 1-10 J/cm2 for 315 nm, and 0.1 J/cm2 around 300 nm. As has been previously observed, the MMD is roughly independent of skin phototype. See, e.g., Parrish J A, Jaenicke K F, Anderson R R. Erythema and melanogenesis action spectra of normal human skin. Photochem Photobiol Vol. 36, pp 187-191, 1982, which is incorporated herein by reference, in its entirety.
  • [0022]
    From a practical standpoint one must recognize that there are some issues that need to be addressed in connection with using LEDs. At present LED performance is best in the visible and infrared, and falls rapidly at the shorter wavelengths of the UVA range. Examples of high performance UV LEDs that are commercially available are the NSHU550A and NSHU590A LEDs from Nichia Corporation, Japan. These parts provide 2.0 and 1.4 mW of UVA light centered at 375 nm, respectively. In fact, at present, commercial devices below 360 nm are not readily available. Choosing appropriate LED devices becomes a trade-off between shorter wavelengths, that are more effective, and longer wavelengths at which efficient and practical LED devices can be obtained.
  • [0023]
    Reasonably high flux devices with a central emission band below 400 nm and above 365 nm can be obtained using some currently available LEDs. The MMD's in this band are in the low 100's of J/cm2. For treatments that are reasonably short duration (<1 hr total), and are somewhat above the MMD (for example, 500 J/cm2), irradiances of at least 100 mW/cm2 are desired. Close packed arrays of sub-400 nm devices are commercially available (one example the Shark OTL-395A-5-10-66 available from OptoTech, Inc., Wheeling, Ill.). At distances of a few millimeters, these arrays provide measured irradiances of up to 200 mW in an approximately 1 cm2 emitting area. The wavelength center of this array was measured to be 395 nm. An arrangement of such LED arrays in close proximity to a person's skin can be used to produce a uniformly high irradiance of near-UVA, sub-400 nm illumination field.
  • [0024]
    Similarly, the LEDs provided by Nichia Corporation, which can be obtained in 5 mm diameter packages, can be used to produce as much as 5 mW/cm2 of 375 nm light on skin. The approximately 20 reduction in irradiance with these LEDs compared to the example above is partially offset by the factor of 3 decrease in the MMD required at this somewhat shorter wavelength, as is illustrated in FIG. 2.
  • [0025]
    Experiments have been performed using a 410 nm LED arrays to treat a patient's face. While melanogenesis is not expected to occur in this waveband, treatment of a dark phototype skin showed obvious IPD after 30 minutes of treatment at approximately 80 mW/cm2 (140 J/cm2 dose). IPD maximum sensitivity falls between 320 and 380 nm.
  • [0026]
    FIG. 3 shows the measured output for an OptoTech 395 Shark LED array. At least 200 mW of power at a wavelength of 395 nm is emitted from an array measuring approximately 1 cm2, when aggressive cooling of the array substrate is provided. This cooling allows the array to be driven past nominal operation current limits to produce up to several hundred mW of potentially melanogenic radiation.
  • [0027]
    Implementation of system 100 with an array module 102 using 395 nm LED arrays should reach the MMD in less than 1 hour of treatment time over a broad treatment area. In embodiment the array module 102 would use approximately 1000 individual LED devices in an array that is designed to treat approximately 50 cm2 area of the face or back, and drives the entire array at approximately 6 A and 45V, or ˜300 W.
  • [0028]
    FIG. 4 shows a cross sectional view of a portion of an array module 402 of a system 400 where spatially controlled UVA is applied to skin. This array module 402 in conjunction with the electronic console, which supplies driving electrical current to the array module, would provide spatially addressable direct UVA treatment. The LEDs 404 are provided which would be mounted to a printed circuit board (not shown). An optically transmissive layer 406 can be positioned adjacent to the emitting area of the LEDs. The embodiment shown in FIG. 4 allows one to spatially tailor the exposure or dose in such a way as to create a custom pigmentation induction profile. This is accomplished by making each individual LEDs 404 addressable with continuously adjustable drive current for LED or groups of LEDs. Addressability of each LED requires significantly more traces on the array printed circuit board or substrate to which the LEDs are mounted and could in some implementations reduce the density that LEDs can be placed in the array.
  • [0029]
    The consequence is that the delivered irradiance is lower than a system where all of the LEDS are subject to a single control and drive current. This reduction depends on the array size, and can be reduced by addressing entire rows or small blocks or regions of LEDs, rather than individual devices.
  • [0030]
    The addressable UVA LED array 402 is positioned so that it is adjacent to the patient's skin 408 which is to be treated. The white regions 410 in the skin represent low melanin content in skin. The areas 412 and 414 represent irradiance which would be delivered from an LED when current is supplied to the particular LED to drive the device. As shown the darker areas 414 correspond to LEDs which would receive higher current and emit higher energy amounts of UVA to the pigment deficient areas of skin 410. In this embodiment, advance knowledge of the desired spatial profile of the treatment dosage or irradiance is required. In operation, an area of the patient's skin which is to be treated would be mapped, and the information would be input to the controller 116 in the electronic console 110. The controller 116 would then cause the driver circuit 112 of the electronic console 110 to output current to regions of LEDS which are positioned to emit UVA to the pigment deficient area of the skin, and other areas which are not pigment deficient would not receive a driving current. It should be noted that depending on the actual implementation each addressable LED region could consist or one or more LEDs.
  • [0031]
    Ideally the LED array would be such that it is capable of providing very high resolution, so that it can provide UVA to those areas which are pigment deficient. In some cases, pigment deficient areas can be as narrow as 1 mm wide.
  • [0032]
    FIG. 5 shows a cross sectional view of a portion of a different embodiment of an array module 502 of a system 500 where spatially controlled UVA is applied to skin. In this embodiment, the individually addressable array of LEDs is similar to that described above in connection with FIG. 4, but additionally included are photodetectors. FIG. 5 shows the individual LEDs 504 mounted to structure 506. As discussed above the structure 506 could be printed circuit board or other structure which provides electrical connections to the LEDs. In addition to LEDs 504 photodetectors 508 are shown. These photodetectors 508 are chosen to be sensitive to light backscattered by the skin 510. The LEDs 504 are positioned in near-contact mode such that they are optically coupled with the skin. As is known, different amounts of pigmentation can have a large effect on the spectral remittance (the amount of light backscattered from the skin). FIG. 8 shows a graph 800 which demonstrates this sensitivity. (The graph 800 reflects known characteristics of the spectral remittance of skin.) Lines 802, 804, 806 and 808 show the relative intensity of back scattered light different areas of skin pigmentation such as dark mole, dark skin, light mole and light skin respectively. As shown, skin bearing different pigmented structures exhibits greatly different diffuse reflectance values at various wavelengths. For UV LEDs operating therapeutically below 375nm, it may be necessary to add some sensing LEDs operating at longer wavelengths. The individual photodetectors 508 will sense the amount of light reflected of the skin, and signals corresponding the amount of light received at each of the photodetectors 508 will then be transmitted by electrical connections to the structure 506, and then via the umbilical chord 108 to the electric console 110. The processor 116 in the electric console 1 10 can then can the correlate the amount of reflected light with an amount of pigment in skin near the detector 508. Based on the amount of reflected light the controller 116 will then cause the driver circuit to supply an amount of current to LEDs 504 which are in the region associated with the particular photodetector 508. In the system 500, as shown in FIG. 5, the arrows 512 represent the direction and strength of the light reflected from the low pigment area 516, and the arrows 514 represent the direction and strength of light reflected from higher pigment areas of skin 5 10. As shown, more light will be reflected from low areas of pigmentation, and as a result the controller will cause the driver circuit to supply more current to LEDs in these low pigment areas.
  • [0033]
    The light from LEDs 504 may serve as the backscattered light that the photodetector 508 senses. In this case, the lack of pigment causes a higher proportion of the UVA light to be backscattered relative to the more UVA-absorbing pigment bearing regions Another embodiment could provide for populating the LED array with a number of alternate wavelength LEDs, where the wavelength of the alternate LEDs could be chosen for maximum contrast in the amount of absorption between pigmented and hypo-pigmented regions (400-550 nm light would be suitable candidate for this purpose—see FIG. 2)
  • [0034]
    In one embodiment the photodetector signals serve as the basis of a control loop for determining the exposure for a given area of skin, and an array of LEDs delivers the appropriate dose profile. In one version, the feedback or servo mechanism is determined at the beginning of treatment, and is not necessarily dynamic. That is, the initial pigment profile determines the spatial profile of the treatment dosing. In still another embodiment, instead of measuring differences only between initial pigmentation, the photodetector array senses dynamically the changes in remittance due to immediate pigment darkening IPD detection, which can then be used to determine the end point of exposure. This can be done in a spatially localized way, as above, or it can be used to determine the end of the overall treatment.
  • [0035]
    Further, it is helpful to recognize that the spectral remittance for dark and light human skin is different. Indeed some prior works have specifically compared dark and light skin phototypes, and developed data showing the difference in the relative amount of UVA-visible light which is backscattered. See, e.g., R. R. Anderson and J. A. Parrish, Optical Properties of Human Skin, p. 159-193, The Science of Photomedicine, 1982, which is incorporated herein by reference in its entirety. See also the data shown in FIG. 8 for diffuse reflectance for different skin pigmentation levels.
  • [0036]
    FIG. 6 is a view of another embodiment herein. In this embodiment an array or arrays LEDS 602 are mounted to a printed circuit board 604 as discussed above. A dome lens 606 would then be provided with each of the LEDs 602. A high index ball lens 608 would then be used to couple the light from LED 602 into a corresponding fiber 61 0. A registration plate 612 for the fibers 61 0 can be used to align the fibers 610 with the array of LEDs 602. A cooling element 614 can be mounted adjacent to the printed circuit board for cooling the LEDs 602, and by providing a temperature conducting path to the LEDs 606. The fibers 610 can then be configured to provide a fiber bundle 616 which could be housed in a hand piece (not shown). Additional aspects of coupling light from an LED into a fiber, and related issues are discussed in more detail in commonly assigned pending U.S. patent application Ser. No. 10/171,101, Spooner et al., “Concentration of Divergent Light from Light Emitting Diodes into Therapeutic Light Energy”, filed Jun. 12, 2002, which is incorporated herein by reference in its entirety.
  • [0037]
    In the system 600 of FIG. 6, the array or arrays of LEDs 602 can be located remotely from the skin, and coupled with high efficiency into individual fibers, which are subsequently bundled 616 to produce a broad area high irradiance illumination handpiece or other optical delivery system. One advantage is that by concentrating the light into fibers 610, a larger maximum treatment irradiance can be obtained (generally at the cost of overall efficiency).
  • [0038]
    The bundle 610 is then placed in near contact with the skin. Actual contact of the bundle or associated delivery against the skin could desirably be minimized. UVA-driven melanogenesis is very strongly dependent on circulatory oxygen. That is, pressing on skin with, say, a window, during phototreatment with a UVA source could drop the response by as much as 10. See, e.g., Auletta M, Gange R W, Tan O T, Matzinger E., Effect of Cutaneous Hypoxia upon erthyma and pigment responses to UVA, UVB and PUVA (8-MOP+UVA) in Human Skin. J Invest Dermatol 86: 649-652, 1986; which is incorporated herein by reference in its entirety, and discusses the effect of circulatory oxygen on phototreatment.
  • [0039]
    FIG. 7 shows an alternative embodiment 700 of the fiber bundle 616 discussed above. The fiber bundle 700 provides in for emitting UVA from LEDs in conjunction with using photodetectors which would be located remotely on a printed circuit board and provide for optical sensing. As shown in FIG. 7 the fibers 702 would be coupled to UVA emitting LEDs. Some of the fibers 706 are not coupled to LEDs, but rather are connected to photosensors or photodetectors. Some fibers 704 may also be connected to a green or other wavelength LED to enhance the sensitivity of the reflectance signal, as discussed above. An advantage of the reflectance sensing and treatment fiber bundle 700 is that can provide better spatial resolution than may be achievable with an addressable array. The required space between LEDs for printed circuit board traces for each device would no longer place a limit on the density with which emitting devices (output coupled fibers, in this case) can be positioned. In this embodiment the position of the detector coupled fibers and the individual LED illuminator fibers would then be mapped, and a controller in the electrical console would determine how much current should be used to drive the individual LEDs or regions of LEDs based on the reflected light received by the fibers which are coupled to the photodetectors.
  • [0040]
    Coupling visible LEDs into large core fibers can result in up to 30% of the light emitted from a domed LED being captured. As multi-milliWatt LEDs in the 365-375 nm range come available, it will be possible to create bundles using fiber coupling to produce irradiances at the bundle output of tens of milliWatts/cm2, sufficient to induce melanogenesis in reasonable treatment times.
  • [0041]
    An additional advantage of the overall fiber bundle approach is that the light treatment handpiece or delivery system can be small and located far from the actual electronics and light generating array(s).
  • [0042]
    Additionally a bundle of fibers or light pipes can be further concentrated, with substantial loss of power, by a secondary guide or reflector. Advantages of this approach include the ability to treat small regions by a hand-applied tip, and the use of even higher irradiances than direct arrays or bundled fibers (as much as 100 mW/cm2 of 365-375 nm may be possible.
  • [0043]
    Although specific embodiments and methods of the present invention are shown and described herein, this invention is not to be limited by these methods and embodiments. Rather, the scope of the invention is to be defined by the following claims and their equivalents.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3538919 *Apr 7, 1967Nov 10, 1970Gregory System IncDepilation by means of laser energy
US3693623 *Dec 25, 1970Sep 26, 1972Gregory System IncPhotocoagulation means and method for depilation
US3834391 *Jan 19, 1973Sep 10, 1974Block Carol LtdMethod and apparatus for photoepilation
US3900034 *Apr 10, 1974Aug 19, 1975Us EnergyPhotochemical stimulation of nerves
US4122853 *Mar 14, 1977Oct 31, 1978Spectra-MedInfrared laser photocautery device
US4388924 *May 21, 1981Jun 21, 1983Weissman Howard RMethod for laser depilation
US4461294 *Jan 20, 1982Jul 24, 1984Baron Neville AApparatus and process for recurving the cornea of an eye
US4608978 *Sep 26, 1983Sep 2, 1986Carol Block LimitedMethod and apparatus for photoepiltion
US4617926 *Jan 30, 1984Oct 21, 1986Sutton A GunillaDepilation device and method
US4733660 *Dec 10, 1986Mar 29, 1988Medical Laser Research And Development CorporationLaser system for providing target specific energy deposition and damage
US4819669 *Apr 1, 1986Apr 11, 1989Politzer Eugene JMethod and apparatus for shaving the beard
US4829262 *Dec 8, 1986May 9, 1989Candela Laser CorporationLong pulse tunable light amplifier
US4917084 *Mar 10, 1988Apr 17, 1990C. R. Bard, Inc.Infrared laser catheter system
US4930504 *Nov 13, 1987Jun 5, 1990Diamantopoulos Costas ADevice for biostimulation of tissue and method for treatment of tissue
US5000752 *Jun 19, 1989Mar 19, 1991William J. HoskinTreatment apparatus and method
US5057104 *May 30, 1989Oct 15, 1991Cyrus ChessMethod and apparatus for treating cutaneous vascular lesions
US5059192 *Apr 24, 1990Oct 22, 1991Nardo ZaiasMethod of hair depilation
US5059798 *May 21, 1991Oct 22, 1991Siemens Gammasonics, Inc.Frangible bonding of photomultiplier tubes for use in scintillation cameras and PET scanners
US5178617 *Jul 9, 1991Jan 12, 1993LaserscopeSystem for controlled distribution of laser dosage
US5182857 *Oct 29, 1990Feb 2, 1993U.S. Philips Corp.Shaving apparatus
US5217455 *Aug 12, 1991Jun 8, 1993Tan Oon TLaser treatment method for removing pigmentations, lesions, and abnormalities from the skin of a living human
US5226907 *Oct 29, 1991Jul 13, 1993Tankovich Nikolai IHair removal device and method
US5290273 *May 25, 1993Mar 1, 1994Tan Oon TLaser treatment method for removing pigement containing lesions from the skin of a living human
US5304170 *Mar 12, 1993Apr 19, 1994Green Howard AMethod of laser-induced tissue necrosis in carotenoid-containing skin structures
US5312395 *Aug 21, 1992May 17, 1994Boston UniversityMethod of treating pigmented lesions using pulsed irradiation
US5344418 *Dec 12, 1991Sep 6, 1994Shahriar GhaffariOptical system for treatment of vascular lesions
US5358503 *Jan 25, 1994Oct 25, 1994Bertwell Dale EPhoto-thermal therapeutic device and method
US5397327 *Jul 27, 1993Mar 14, 1995Coherent, Inc.Surgical laser handpiece for slit incisions
US5405368 *Oct 20, 1992Apr 11, 1995Esc Inc.Method and apparatus for therapeutic electromagnetic treatment
US5425728 *Jan 19, 1993Jun 20, 1995Tankovich; Nicolai I.Hair removal device and method
US5474549 *Feb 18, 1993Dec 12, 1995LaserscopeMethod and system for scanning a laser beam for controlled distribution of laser dosage
US5486172 *Jan 31, 1994Jan 23, 1996Chess; CyrusApparatus for treating cutaneous vascular lesions
US5500009 *Sep 27, 1993Mar 19, 1996Amron, Ltd.Method of treating herpes
US5505726 *Mar 21, 1994Apr 9, 1996Dusa Pharmaceuticals, Inc.Article of manufacture for the photodynamic therapy of dermal lesion
US5522813 *Sep 23, 1994Jun 4, 1996Coherent, Inc.Method of treating veins
US5527350 *Feb 24, 1993Jun 18, 1996Star Medical Technologies, Inc.Pulsed infrared laser treatment of psoriasis
US5531740 *Sep 6, 1994Jul 2, 1996Rapistan Demag CorporationAutomatic color-activated scanning treatment of dermatological conditions by laser
US5549660 *Nov 12, 1992Aug 27, 1996Amron, Ltd.Method of treating acne
US5611795 *Feb 3, 1995Mar 18, 1997Laser Industries, Ltd.Laser facial rejuvenation
US5616140 *Mar 21, 1994Apr 1, 1997Prescott; MarvinMethod and apparatus for therapeutic laser treatment
US5620478 *Jun 7, 1995Apr 15, 1997Esc Medical Systems Ltd.Method and apparatus for therapeutic electromagnetic treatment
US5626631 *Feb 3, 1995May 6, 1997Esc Medical Systems Ltd.Method and apparatus for therapeutic electromagnetic treatment
US5630811 *Mar 25, 1996May 20, 1997Miller; Iain D.Method and apparatus for hair removal
US5658323 *Oct 23, 1995Aug 19, 1997Miller; Iain D.Method and apparatus for dermatology treatment
US5683380 *Mar 29, 1995Nov 4, 1997Esc Medical Systems Ltd.Method and apparatus for depilation using pulsed electromagnetic radiation
US5735844 *Jan 30, 1996Apr 7, 1998The General Hospital CorporationHair removal using optical pulses
US5738679 *Jun 26, 1996Apr 14, 1998S.L.T. Japan Company LimitedApparatus for laser treatment for living tissue
US5743679 *Aug 2, 1996Apr 28, 1998Dbt Deutsche Bergbau-Technik GmbhHydraulic shield support frame
US5743901 *May 15, 1996Apr 28, 1998Star Medical Technologies, Inc.High fluence diode laser device and method for the fabrication and use thereof
US5769787 *Jun 7, 1995Jun 23, 1998Lemelson; Jerome H.Medical scanning and treatment system and method
US5800479 *Jan 19, 1995Sep 1, 1998Biolight Patent Holding AbDevice for medical external treatment by means of light
US5820625 *Nov 27, 1996Oct 13, 1998Ya-Man Ltd.Light depilating apparatus
US5944748 *Jul 25, 1997Aug 31, 1999Light Medicine, Inc.Photodynamic therapy apparatus and methods
US5957960 *May 5, 1997Sep 28, 1999Light Sciences Limited PartnershipInternal two photon excitation device for delivery of PDT to diffuse abnormal cells
US5964749 *Sep 15, 1995Oct 12, 1999Esc Medical Systems Ltd.Method and apparatus for skin rejuvenation and wrinkle smoothing
US6063108 *Jan 6, 1997May 16, 2000Salansky; NormanMethod and apparatus for localized low energy photon therapy (LEPT)
US6074382 *Nov 19, 1997Jun 13, 2000Asah Medico A/SApparatus for tissue treatment
US6080147 *Jun 10, 1998Jun 27, 2000Tobinick; Edward L.Method of employing a flashlamp for removal of hair, veins and capillaries
US6106514 *Oct 3, 1997Aug 22, 2000O'donnell, Jr.; Francis E.Laser method for subsurface cutaneous treatment
US6159236 *Jan 28, 1999Dec 12, 2000Advanced Photodynamic Technologies, Inc.Expandable treatment device for photodynamic therapy and method of using same
US6210425 *Jul 8, 1999Apr 3, 2001Light Sciences CorporationCombined imaging and PDT delivery system
US6228075 *Mar 15, 1999May 8, 2001Cynosure, Inc.Alexandrite laser system for hair removal
US6237884 *Jun 3, 1999May 29, 2001Stephen E. HoweCeiling fan mounting assembly
US6238424 *Jun 4, 1997May 29, 2001Biolight Patent Holding AbDevice for external treatment with pulsating light of high duty cycle
US6238425 *Jun 4, 1997May 29, 2001Biolight Patent Holding AbDevice for external medical treatment with monochromatic light
US6251127 *Aug 25, 1998Jun 26, 2001Advanced Photodynamic Technologies, Inc.Dye treatment solution and photodynamic therapy and method of using same
US6273884 *May 13, 1998Aug 14, 2001Palomar Medical Technologies, Inc.Method and apparatus for dermatology treatment
US6273885 *Aug 16, 1998Aug 14, 2001Cooltouch CorporationHandheld photoepilation device and method
US6290713 *Aug 24, 1999Sep 18, 2001Thomas A. RussellFlexible illuminators for phototherapy
US6306130 *Apr 7, 1999Oct 23, 2001The General Hospital CorporationApparatus and methods for removing blood vessels
US6350275 *Jun 9, 1998Feb 26, 2002The Board Of Trustees Of The Leland Stanford Junior UniversityDevices for treating circadian rhythm disorders using LED's
US6383176 *Mar 15, 1999May 7, 2002Altus Medical, Inc.Hair removal device and method
US6383177 *Dec 13, 1999May 7, 2002Asah Medico A/SApparatus for tissue treatment
US6413267 *Aug 9, 1999Jul 2, 2002Theralase, Inc.Therapeutic laser device and method including noninvasive subsurface monitoring and controlling means
US6443978 *Apr 9, 1999Sep 3, 2002Board Of Trustees Of The University Of ArkansasPhotomatrix device
US6494900 *Jan 31, 2000Dec 17, 2002Norman SalanskyMethod for localized low energy photon therapy (LEPT)
US6524329 *Mar 8, 2001Feb 25, 2003Tru-Light CorporationBody processing using light
US6537302 *Jan 19, 2000Mar 25, 2003Biolight Patent Holding AbMeans for external medical treatment by means of light
US6569155 *Mar 13, 2000May 27, 2003Altus Medical, Inc.Radiation delivery module and dermal tissue treatment method
US6596016 *Apr 19, 2000Jul 22, 2003The Board Of Trustees Of The Leland Stanford Junior UniversityPhototherapy of jaundiced newborns using garments containing semiconductor light-emitting devices
US6676654 *Sep 13, 2000Jan 13, 2004Asah Medico A/SApparatus for tissue treatment and having a monitor for display of tissue features
US6860896 *Sep 3, 2002Mar 1, 2005Jeffrey T. SamsonTherapeutic method and apparatus
US7070611 *Jul 29, 2002Jul 4, 2006Advanced Photodynamic Technologies, Inc.Treatment device for topical photodynamic therapy and method of using same
US7311722 *Jan 22, 2002Dec 25, 2007Eric LarsenPhotodynamic stimulation device and methods
US20020029071 *Mar 23, 2001Mar 7, 2002Colin WhitehurstTherapeutic light source and method
US20020120312 *Feb 18, 2002Aug 29, 2002Ignatius Ronald W.Device for the treatment of mucositis
US20020143373 *Jan 25, 2002Oct 3, 2002Courtnage Peter A.System and method for therapeutic application of energy
US20030004499 *Jun 29, 2001Jan 2, 2003Mcdaniel David H.Method and apparatus for the photomodulation of living cells
US20030009205 *Jul 29, 2002Jan 9, 2003Biel Merrill A.Treatment device for topical photodynamic therapy and method of using same
US20030023283 *Nov 8, 2001Jan 30, 2003Mcdaniel David H.Method and apparatus for the stimulation of hair growth
US20030040738 *Jul 30, 2002Feb 27, 2003Ruiz Luis AntonioControllable liquid crystal matrix mask particularly suited for performing ophthamological surgery, a laser system with said mask and a method of using the same
US20030117491 *Jul 25, 2002Jun 26, 2003Dov AvniApparatus and method for controlling illumination in an in-vivo imaging device
US20030233138 *Jun 12, 2002Dec 18, 2003Altus Medical, Inc.Concentration of divergent light from light emitting diodes into therapeutic light energy
US20040044384 *Sep 3, 2002Mar 4, 2004Leber Leland C.Therapeutic method and apparatus
US20040068305 *Oct 7, 2002Apr 8, 2004Vineet BansalPhototherapy system and device
US20040111132 *Dec 10, 2002Jun 10, 2004Olga ShenderovaPhototherapeutic treatment methods and apparatus
US20050004631 *May 31, 2002Jan 6, 2005Mellen-Thomas BenedictLight processing of selected body components
USRE36634 *Sep 5, 1996Mar 28, 2000Ghaffari; ShahriarOptical system for treatment of vascular lesions
USRE38670 *Oct 11, 2001Dec 14, 2004Asah Medico A/SApparatus for tissue treatment
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7935107May 3, 2011Palomar Medical Technologies, Inc.Heads for dermatology treatment
US7942915Nov 13, 2006May 17, 2011Palomar Medical Technologies, Inc.Phototreatment device for use with coolants
US7942916Dec 1, 2006May 17, 2011Palomar Medical Technologies, Inc.Phototreatment device for use with coolants and topical substances
US8002768Aug 23, 2011Palomar Medical Technologies, Inc.Light energy delivery head
US8109924Feb 7, 2012Palomar Medical Technologies, Inc.Heads for dermatology treatment
US8182473Nov 22, 2006May 22, 2012Palomar Medical TechnologiesCooling system for a photocosmetic device
US8328794Sep 22, 2008Dec 11, 2012Palomar Medical Technologies, Inc.System for electromagnetic radiation dermatology and head for use therewith
US8328796Jul 11, 2011Dec 11, 2012Palomar Medical Technologies, Inc.Light energy delivery head
US8346347Jan 1, 2013Palomar Medical Technologies, Inc.Skin optical characterization device
US8425577Apr 23, 2013Joanna VargasLED phototherapy apparatus
US8915948Feb 15, 2008Dec 23, 2014Palomar Medical Technologies, LlcMethod and apparatus for photothermal treatment of tissue at depth
US9028536Aug 3, 2009May 12, 2015Cynosure, Inc.Picosecond laser apparatus and methods for its operation and use
US20070060819 *Sep 15, 2006Mar 15, 2007Palomar Medical Technologies, Inc.Skin optical characterization device
US20070239145 *Apr 2, 2007Oct 11, 2007Raphael LadermanSystem and method to assist in the treatment of skin conditions
US20080082090 *Dec 7, 2007Apr 3, 2008The General Hospital CorporationMethod and apparatus for dermatological treatment and tissue reshaping
US20100145322 *Dec 4, 2007Jun 10, 2010Roberto PiniLed device for the haemostasis of blood vessels
US20100158462 *Dec 17, 2009Jun 24, 2010Bonitatibus Michael HSunlight Simulator Apparatus
Classifications
U.S. Classification607/88
International ClassificationA61N5/06
Cooperative ClassificationA61N2005/0645, A61N5/0614, A61N2005/0652, A61N2005/0661
European ClassificationA61N5/06C1